申请人:——
公开号:US20040198701A1
公开(公告)日:2004-10-07
This invention relates to potent selective agonists of the EP
4
subtype of prostaglandin E2 receptors, their use or a formulation thereof in the treatment of glaucoma and other conditions, which are related to elevated intraocular pressure in the eye of a patient. This invention further relates to the use of the compounds of this invention for mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts.
这项发明涉及到前列腺素E2受体EP4亚型的强效选择性激动剂,以及它们在治疗青光眼和其他与患者眼内高眼压相关的疾病中的使用或配方。此发明还涉及将本发明的化合物用于介导成骨细胞和破骨细胞的骨建模和重塑过程。